Χώρα: Σιγκαπούρη
Γλώσσα: Αγγλικά
Πηγή: HSA (Health Sciences Authority)
RISEDRONATE SODIUM
SANOFI-AVENTIS SINGAPORE PTE. LTD.
M05BA07
5 mg
TABLET, FILM COATED
ORAL
Prescription Only
NORWICH PHARMACEUTICALS INC
2001-06-21
_Actonel_ ® 5mg _ _ _Risedronate sodium _ film-coated tablet [sanofi aventis logo] 1 NAME OF THE MEDICINAL PRODUCT Actonel 5 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 5 mg risedronate sodium (equivalent to 4.64 mg risedronic acid). For excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets. Oval yellow film-coated tablet with RSN on one side and 5 mg on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • Treatment of postmenopausal osteoporosis, to reduce the risk of vertebral fractures. • Treatment of established postmenopausal osteoporosis, to reduce the risk of hip fractures. • Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis (see section 5.1). • To maintain or increase bone mass in postmenopausal women undergoing long-term (more than 3 months), systemic corticosteroid treatment at doses ≥ 7.5mg/day prednisone or equivalent. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended daily dose in adults is one 5 mg tablet orally. The absorption of Actonel is affected by food, thus to ensure adequate absorption patients should take Actonel: • Before breakfast: At least 30 minutes before the first food, other medicinal product or drink (other than plain water) of the day. In the particular instance that before breakfast dosing is not practical, Actonel can be taken between meals or in the evening at the same time everyday, with strict adherence to the following instructions, to ensure Actonel is taken on an empty stomach: • Between meals: Actonel should be taken at least 2 hours before and at least Διαβάστε το πλήρες έγγραφο